Shanghai, Argo

Shanghai Argo Announces Multi-Program RNAi Licenses and Strategic Collaborations with Novartis

Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk

Shanghai Argo Biopharmaceutical Co., Ltd. China

View original content:https://www.prnewswire.co.uk/news-releases/shanghai-argo-announces-multi-program-rnai-licenses-and-strategic-collaborations-with-novartis-302027706.html

en | boerse | 67930135 |